ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

on: April 21, 2025In: Evolving Standards of Care
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

In this Q&A, Dr. Luis E. Raez and nurse practitioner Beth Sandy discuss recently reported MARIPOSA data in the context of current standard of care and provide best practices for therapeutic selection and patient education. Read more

The Elephant in the Room: Addressing Oncology’s Carbon Footprint

Haleigh Behrman
on: May 13, 2025In: Evolving Standards of Care, Radiation Oncology
The Elephant in the Room: Addressing Oncology’s Carbon Footprint

From travel-related emissions to medical waste, Drs. Puneeth Iyengar and Edward Christopher Dee discuss the environmental impact of radiotherapy. Read more

Up in the Air: A Patient’s Perspective on Navigating Lung Cancer Treatment During One of the Most Devastating Wildfires in US History

Haleigh Behrman
on: April 22, 2025In: Evolving Standards of Care, Global Initiatives, Patient Advocacy
Up in the Air: A Patient’s Perspective on Navigating Lung Cancer Treatment During One of the Most Devastating Wildfires in US History

Lynn Lieberman was already in a fight against lung cancer, but she faced a second battle when the Los Angeles wildfires spread throughout her community. Read more

Foritinib Gains Momentum in China for ALK-positive NSCLC

Haleigh Behrman
on: April 08, 2025In: Evolving Standards of Care, Industry News & Regulatory Approvals, Society News
Foritinib Gains Momentum in China for ALK-positive NSCLC

China’s NMPA accepts a marketing authorization application for foritinib following interim results from the phase III REMARK trial. Read more

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

Maaike van den Bos, MD
+more
on: March 25, 2025In: Evolving Standards of Care, Palliative Care, Society News
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

Anti-obesity medications could theoretically reduce the absorption of oral TKIs, particularly in cases of lipophilicity, where therapeutic agents have a strong dependence on dietary fat for adequate dissolution. Read more

Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
Combination Therapies as Frontline Treatment for EGFR-Mutated NSCLC: Are the Rewards Worth the Risks?

During a TTLC debate, Drs. Helena Yu and Shirish Gadgeel weighed the pros and limitations of osimertinib monotherapy and combination therapies. Read more

With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Meeting News, Names & News
With Data on Her Side, Dr. Anne Tsao Dominates Debate on Merits of Chemo-IO for Mesothelioma

Lacking evidence to argue against combinations in this patient population, Dr. Penelope Bradbury, turned to humor to make her case. Read more

Picking Up the Pieces: The Impact of the Western US Wildfires on Cancer Care

Haleigh Behrman
on: March 25, 2025In: Evolving Standards of Care, Global Initiatives, Patient Advocacy
Picking Up the Pieces: The Impact of the Western US Wildfires on Cancer Care

Dr. Karen Reckamp discusses the challenges that both patients and oncologists in the Los Angeles area experienced during the devastating fires. Read more

Updated Data Show Median OS of 16.9 months in Patients with Advanced NSCLC Treated with THIO

Haleigh Behrman
on: March 11, 2025In: Evolving Standards of Care, Industry News & Regulatory Approvals, Society News
Updated Data Show Median OS of 16.9 months in Patients with Advanced NSCLC Treated with THIO

Though the study is small, the sponsor says results are promising for the first-in-class telomere-targeting agent. Read more

US FDA Grants Priority Review for Zongertinib for Advanced HER2+ NSCLC

Haleigh Behrman
on: March 11, 2025In: Evolving Standards of Care, Industry News & Regulatory Approvals, Society News
US FDA Grants Priority Review for Zongertinib for Advanced HER2+ NSCLC

Data from the Beamion LUNG-1 trial show a 71% objective response rate in previously treated patients. Read more

Healthcare Community Can Still Take Action to Combat Effects of Climate Change

Leticia Nogueira, PhD, MPH
on: February 25, 2025In: Evolving Standards of Care, Global Initiatives, Risk Assessment and Reduction
Healthcare Community Can Still Take Action to Combat Effects of Climate Change

Dr. Leticia Nogueira says the time has come for the lung cancer community to champion environmentally responsible practices that help mitigate cancer risks and outcomes. Read more

1234›»

SEARCH ILCN

Archives

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy